Erschienen in:
21.01.2022
Characterization of a paradoxical post-operative increase in serum cortisol in Cushing disease
verfasst von:
Michael P. Catalino, Aaron Gelinne, Natasha Ironside, Justin Coley, Rachel Jonas, Kathryn Kearns, Alexander Munoz, Alaa Montaser, Mary Lee Vance, John A. Jane Jr, Edward R. Laws Jr
Erschienen in:
Pituitary
|
Ausgabe 2/2022
Einloggen, um Zugang zu erhalten
Abstract
Purpose
In Cushing disease, early post-operative serum cortisol fluctuations have not been adequately characterized, and their association with initial remission and recurrence is unclear.
Methods
A retrospective cohort study of patients with Cushing disease was conducted at two institutions. A “riser” was defined a priori as a paradoxical increase in serum cortisol with an immediate incremental increase in serum cortisol over three consecutive cortisol draws separated by roughly 6-h (definition 1). Post hoc analyses used a definition of two consecutive increases (definition 2). Risers were compared to non-risers for initial remission and time-to-recurrence.
Results
A total of 505 patients with Cushing disease were screened, and 469 had adequate data for group assignment. Analysis of post-operative cortisol showed a subgroup of “risers” with a frequency of 3.6% for definition 1 and 42.6% for definition 2. In these patients, cortisol levels were significantly higher until approximately 36 h post-operatively, and cortisol had a significantly longer mean serum half-life. In the post hoc analysis, definition 2 risers had a lower remission rate compared to non-risers (162/196, 82.7%, versus 243/264, 92.0%) with an odds ratio of 0.41 (0.23–0.73; p = 0.003). For both definitions, recurrence was similar between groups.
Conclusions
We found that almost half of Cushing disease patients experienced a temporary increase in serum cortisol level during the early post-operative period. Serum cortisol half-life was longer, and the remission rates were lower, however, recurrence rates were similar to non-risers.